Protein Therapeutics Market, By Product Type (Monoclonal Antibodies (mAbs), Insulin and Analogues, Recombinant Proteins, Fusion Proteins, Blood Factors, Human Growth Hormones (hGH), Follicle-Stimulating Hormone (FSH), Interferons, and Others (e.g., Erythropoietin, etc.)), By Application (Cancer Treatment, Autoimmune Diseases, Infectious Diseases, Hemophilia and Coagulation Disorders, Diabetes, Cardiovascular Diseases, Neurological Disorders, and Genetic Disorders), By Technology (Recombinant DNA Technology, Cell-Based Technology, Hybridoma Technology, and Others (Gene Editing, Transfection)), By Route of Administration (Parenteral (Injectables), Oral, and Others (Topical, Nasal)),By End User: Hospitals, Clinics, Research Laboratories, and Pharmaceutical and Biotechnology Companies